Use of okadaic acid to identify relevant phosphoepitopes in pathology: A focus on neurodegeneration

Marine Drugs

Volumn 11, Issue 5, 2013, Pages 1656-1668

  Medina, Miguel ^a   Avila, Jesús ^a,b   Villanueva, Nieves ^c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Alzheimer; GSK 3; Kinases; Neurodegeneration; Okadaic acid; Phosphatases; Phosphorylation; PP2A; Tangles; Tau

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; EPITOPE; OKADAIC ACID; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; TAU PROTEIN; TUMOR PROMOTER;

ENZYME ACTIVITY; HUMAN; NERVE DEGENERATION; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; REVIEW; X RAY CRYSTALLOGRAPHY;

EID: 84878288130     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11051656     Document Type: Review

References (88)

1. Tachibana, K.; Scheuer, P.J.; Tsukitani, Y.; Kikuchi, K.; Vanengen, D.C.J.; Gopichand, Y.; Schmitz, F.J. Okadaic acid, a cyto-toxic polyether from 2 marine sponges of the genus Halichondria. J. Am. Chem. Soc. 1981, 103, 2469-2471.
2. Cembella, A. Occurrence of okadaic acid, a major diarrheic shellfish toxin, in natural populations of Dinophysis spp. from the eastern coast of North America. J. Appl. Phycol. 1990, 1, 307-310.
3. Dickey, R.W.; Bobzin, S.C.; Faulkner, D.J.; Bencsath, F.A.; Andrzejewski, D. Identification of okadaic acid from a Caribbean dinoflagellate, Prorocentrum concavum. Toxicon 1990, 28, 371-377. (Pubitemid 20156693)
4. Yasumoto, T.; Murata, M.; Oshima, Y.; Sano, M.; Matsumoto, G.K.; Clardy, J. Diarrheic shellfish toxin. Tetrahedron 1985, 41, 1019-1025.
5. Kumagai, M.; Yamagi, T.; Murata, M.; Yasumoto, T.; Kat, M.; Lassus, P.; Rodriguez-Vazquez, J.A. Okadaic acid as the causative toxin of diarrheic shellfish poisoning in Europe. Agric. Biol. Chem. 1986, 50, 2857-2863.
6. Pistocchi, R.; Guerrini, F.; Pezzolesi, L.; Riccardi, M.; Vanucci, S.; Ciminiello, P.; Del'Aversano, C.; Forino, M.; Fattorusso, E.; Tartaglione, L.; et al. Toxin levels and profiles in microalgae from the North-Western Adriatic Sea - 15 years of studies on cultured species. Mar. Drugs 2012, 10, 140-162.
7. Edebo, L.; Lange, S.; Li, X.P.; Allenmark, S. Toxic mussels and okadaic acid induce rapid hypersecretion in the rat small intestine. APMIS 1988, 96, 1029-1035. (Pubitemid 19007391)
8. Ito, E.; Terao, K. Injury and recovery process of intestine caused by okadaic acid and related compounds. Nat. Toxins 1994, 2, 371-377.
9. Franchini, A.; Marchesini, E.; Poletti, R.; Ottaviani, E. Swiss mice CD1 fed on mussels contaminated by okadaic acid and yessotoxins: Effects on thymus and spleen. Eur. J. Histochem. 2005, 49, 73-82.
10. Ito, E.; Yasumoto, T.; Takai, A.; Imanishi, S.; Harada, K. Investigation of the distribution and excretion of okadaic acid in mice using immunostaining method. Toxicon 2002, 40, 159-165. (Pubitemid 33016545)
11. Franchini, A.; Malagoli, D.; Ottaviani, E. Targets and effects of yessotoxin, okadaic acid and palytoxin: A differential review. Mar. Drugs 2010, 8, 658-677.
12. Berven, G.; Saetre, F.; Halvorsen, K.; Seglen, P.O. Effects of the diarrhetic shellfish toxin, okadaic acid, on cytoskeletal elements, viability and functionality of rat liver and intestinal cells. Toxicon 2001, 39, 349-362. (Pubitemid 30649083)
13. Dounay, A.B.; Forsyth, C.J. Okadaic acid: The archetypal serine/threonine protein phosphatase inhibitor. Curr. Med. Chem. 2002, 9, 1939-1980. (Pubitemid 35256499)
14. Suganuma, M.; Fujiki, H.; Suguri, H.; Yoshizawa, S.; Hirota, M.; Nakayasu, M.; Ojika, M.; Wakamatsu, K.; Yamada, K.; Sugimura, T. Okadaic acid: An additional non-phorbol-12-tetrade canoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA 1988, 85, 1768-1771. (Pubitemid 24315763)
15. Sontag, J.M.; Sontag, E. Regulation of cell adhesion by PP2A and SV40 small tumor antigen: An important link to cell transformation. Cell Mol. Life Sci. 2006, 63, 2979-2991. (Pubitemid 46072303)
16. Fujiki, H.; Suganuma, M. Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors. Prog. Mol. Subcell. Biol. 2009, 46, 221-254.
17. Bialojan, C.; Takai, A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 1988, 256, 283-290.
18. Munday, R. Is protein phosphatase inhibition responsible for the toxic effects of okadaic acid in animals? Toxins (Basel) 2013, 5, 267-285.
19. Cohen, P. Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol. 1991, 201, 389-398.
20. Swingle, M.; Ni, L.; Honkanen, R.E. Small-molecule inhibitors of ser/thr protein phosphatases: Specificity, use and common forms of abuse. Methods Mol. Biol. 2007, 365, 23-38.
21. Sakoff, J.A.; McCluskey, A. Protein phosphatase inhibition: Structure based design. Towards new therapeutic agents. Curr. Pharm. Des. 2004, 10, 1139-1159. (Pubitemid 38425896)
22. Cohen, P.; Holmes, C.F.; Tsukitani, Y. Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem. Sci. 1990, 15, 98-102.
23. Fernandez, J.J.; Candenas, M.L.; Souto, M.L.; Trujillo, M.M.; Norte, M. Okadaic acid, useful tool for studying cellular processes. Curr. Med. Chem. 2002, 9, 229-262. (Pubitemid 34436443)
24. Medina, M.; Garcia-Rocha, M.; Padilla, R.; Perez, M.; Montejo de Garcini, E.; Avila, J. Protein kinases involved in the phosphorylation of human tau protein in transfected COS-1 cells. Biochim. Biophys. Acta 1996, 1316, 43-50. (Pubitemid 26174920)
25. Medina, M.; Montejo de Garcini, E.; Avila, J. The role of tau phosphorylation in transfected COS-1 cells. Mol. Cell Biochem. 1995, 148, 79-88.
26. Vale, C.; Botana, L.M. Marine toxins and the cytoskeleton: Okadaic acid and dinophysistoxins. FEBS J. 2008, 275, 6060-6066.
27. Herschman, H.R.; Lim, R.W.; Brankow, D.W.; Fujiki, H. The tumor promoters 12-O-tetradecanoylphorbol-13-acetate and okadaic acid differ in toxicity, mitogenic activity and induction of gene expression. Carcinogenesis 1989, 10, 1495-1498. (Pubitemid 19197472)
28. Sassa, T.; Richter, W.W.; Uda, N.; Suganuma, M.; Suguri, H.; Yoshizawa, S.; Hirota, M.; Fujiki, H. Apparent "activation" of protein kinases by okadaic acid class tumor promoters. Biochem. Biophys. Res. Commun. 1989, 159, 939-944. (Pubitemid 19101073)
29. Albano, C.; Ronzitti, G.; Rossini, A.M.; Callegari, F.; Rossini, G.P. The total activity of a mixture of okadaic acid-group compounds can be calculated by those of individual analogues in a phosphoprotein phosphatase 2A assay. Toxicon 2009, 53, 631-637.
30. Garibo, D.; Dàmaso, E.; Eixarch, H.; de la Iglesia, P.; Fernández-Tejedor, M.; Diogène, J.; Pazos, Y.; Campàs, M. Protein phosphatase inhibition assays for okadaic acid detection in shellfish: Matrix effects, applicability and comparison with LC-MS/MS analysis. Harmful Algae 2012, 19, 68-75.
31. Asenjo, A.; Villanueva, N. Regulated but not constitutive human respiratory syncytial virus (HRSV) P protein phosphorylation is essential for oligomerization. FEBS Lett. 2000, 467, 279-284. (Pubitemid 30081750)
32. Asenjo, A.; Rodriguez, L.; Villanueva, N. Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: A possible role for serine 54. J. Gen. Virol. 2005, 86, 1109-1120. (Pubitemid 40485669)
33. Asenjo, A.; Calvo, E.; Villanueva, N. Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J. Gen. Virol. 2006, 87, 3637-3642. (Pubitemid 44816996)
34. Asenjo, A.; Gonzalez-Armas, J.C.; Villanueva, N. Phosphorylation of human respiratory syncytial virus P protein at serine 54 regulates viral uncoating. Virology 2008, 380, 26-33.
35. Huber, J.L.; Huber, S.C. Site-specific serine phosphorylation of spinach leaf sucrose-phosphate synthase. Biochem. J. 1992, 283, 877-882.
36. Fernandez, M.T.; Zitko, V.; Gascon, S.; Novelli, A. The marine toxin okadaic acid is a potent neurotoxin for cultured cerebellar neurons. Life Sci. 1991, 49, 157-162.
37. Leira, F.; Alvarez, C.; Vieites, J.M.; Vieytes, M.R.; Botana, L.M. Characterization of distinct apoptotic changes induced by okadaic acid and yessotoxin in the BE(2)-M17 neuroblastoma cell line. Toxicol. In Vitro 2002, 16, 23-31. (Pubitemid 34112633)
38. Zhang, Z.; Simpkins, J.W. An okadaic acid-induced model of tauopathy and cognitive deficiency. Brain Res. 2010, 1359, 233-246.
39. Chen, Z.; Chen, B.; Xu, W.F.; Liu, R.F.; Yang, J.; Yu, C.X. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model. Int. J. Dev. Neurosci. 2012, 30, 411-419.
40. Martin, L.; Page, G.; Terro, F. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3beta. Neurochem. Int. 2011, 59, 235-250.
41. Kim, S.M.; Yoon, S.Y.; Choi, J.E.; Park, J.S.; Choi, J.M.; Nguyen, T.; Kim, D.H. Activation of eukaryotic initiation factor-2 alpha-kinases in okadaic acid-treated neurons. Neuroscience 2010, 169, 1831-1839.
42. Ho, Y.S.; Yang, X.; Lau, J.C.; Hung, C.H.; Wuwongse, S.; Zhang, Q.; Wang, J.; Baum, L.; So, K.F.; Chang, R.C. Endoplasmic reticulum stress induces tau pathology and forms a vicious cycle: Implication in Alzheimer's disease pathogenesis. J. Alzheimer's Dis. 2012, 28, 839-854.
43. Krinke, D.; Jahnke, H.G.; Mack, T.G.; Hirche, A.; Striggow, F.; Robitzki, A.A. A novel organotypic tauopathy model on a new microcavity chip for bioelectronic label-free and real time monitoring. Biosens. Bioelectron. 2010, 26, 162-168.
44. Ekinci, F.J.; Ortiz, D.; Shea, T.B. Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel. Brain Res. Mol. Brain Res. 2003, 117, 145-151. (Pubitemid 38366027)
45. Yoon, S.Y.; Choi, J.E.; Yoon, J.H.; Huh, J.W.; Kim, D.H. BACE inhibitor reduces APP-beta-C -terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis. 2006, 22, 435-444.
46. Yoon, S.Y.; Choi, J.E.; Ham, J.H.; Choe, H.; Lee, H.S.; Kim, D.H. zVLL-CHO at low concentrations acts as a calpain inhibitor to protect neurons against okadaic acid-induced neurodegeneration. Neurosci. Lett. 2012, 509, 33-38.
47. Del Barrio, L.; Martin-de-Saavedra, M.D.; Romero, A.; Parada, E.; Egea, J.; Avila, J.; McIntosh, J.M.; Wonnacott, S.; Lopez, M.G. Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by alpha7 and beta2*nicotinic stimulation. Toxicol. Sci. 2011, 123, 193-205.
48. Rudrabhatla, P.; Albers, W.; Pant, H.C. Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins. J. Neurosci. 2009, 29, 14869-14880.
49. Valdiglesias, V.; Fernandez-Tajes, J.; Pasaro, E.; Mendez, J.; Laffon, B. Identification of differentially expressed genes in SHSY5Y cells exposed to okadaic acid by suppression subtractive hybridization. BMC Genomics 2012, 13, 46.
50. Pei, J.J.; Gong, C.X.; An, W.L.; Winblad, B.; Cowburn, R.F.; Grundke-Iqbal, I.; Iqbal, K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am. J. Pathol. 2003, 163, 845-858. (Pubitemid 37040121)
51. Nelson, P.T.; Saper, C.B. Injections of okadaic acid, but not beta-amyloid peptide, induce Alz-50 immunoreactive dystrophic neurites in the cerebral cortex of sheep. Neurosci. Lett. 1996, 208, 77-80. (Pubitemid 26128112)
52. Arias, C.; Becerra-Garcia, F.; Arrieta, I.; Tapia, R. The protein phosphatase inhibitor okadaic acid induces heat shock protein expression and neurodegeneration in rat hippocampus in vivo. Exp. Neurol. 1998, 153, 242-254. (Pubitemid 28489891)
53. Arendt, T.; Holzer, M.; Fruth, R.; Bruckner, M.K.; Gartner, U. Phosphorylation of tau, abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A. Neurobiol. Aging 1998, 19, 3-13. (Pubitemid 28167790)
54. Tapia, R.; Pena, F.; Arias, C. Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases. Neurochem. Res. 1999, 24, 1423-1430. (Pubitemid 29505952)
55. He, J.; Yamada, K.; Zou, L.B.; Nabeshima, T. Spatial memory deficit and neurodegeneration induced by the direct injection of okadaic acid into the hippocampus in rats. J. Neural Transm. 2001, 108, 1435-1443. (Pubitemid 34020447)
56. Kamat, P.K.; Tota, S.; Rai, S.; Shukla, R.; Ali, S.; Najmi, A.K.; Nath, C. Okadaic acid induced neurotoxicity leads to central cholinergic dysfunction in rats. Eur. J. Pharmacol. 2012, 690, 90-98.
57. Costa, A.P.; Tramontina, A.C.; Biasibetti, R.; Batassini, C.; Lopes, M.W.; Wartchow, K.M.; Bernardi, C.; Tortorelli, L.S.; Leal, R.B.; Goncalves, C.A. Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia. Behav. Brain Res. 2012, 226, 420-427.
58. Zhou, X.W.; Gustafsson, J.A.; Tanila, H.; Bjorkdahl, C.; Liu, R.; Winblad, B.; Pei, J.J. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol. Dis. 2008, 31, 386-394.
59. Arendt, T.; Hanisch, F.; Holzer, M.; Bruckner, M.K. In vivo phosphorylation in the rat basal nucleus induces PHF-like and APP immunoreactivity. Neuroreport 1994, 5, 1397-1400. (Pubitemid 24219242)
60. Braithwaite, S.P.; Stock, J.B.; Lombroso, P.J.; Nairn, A.C. Protein phosphatases and Alzheimer's disease. Prog. Mol. Biol. Transl. Sci. 2012, 106, 343-379.
61. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298, 789-791. (Pubitemid 35231524)
62. Drechsel, D.N.; Hyman, A.A.; Cobb, M.H.; Kirschner, M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell 1992, 3, 1141-1154. (Pubitemid 23088964)
63. LoPresti, P.; Szuchet, S.; Papasozomenos, S.C.; Zinkowski, R.P.; Binder, L.I. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes. Proc. Natl. Acad. Sci. USA 1995, 92, 10369-10373.
64. Ebneth, A.; Godemann, R.; Stamer, K.; Illenberger, S.; Trinczek, B.; Mandelkow, E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J. Cell Biol. 1998, 143, 777-794. (Pubitemid 28512571)
65. Goedert, M.; Spillantini, M.G.; Potier, M.C.; Ulrich, J.; Crowther, R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: Differential expression of tau protein mRNAs in human brain. EMBO J. 1989, 8, 393-399. (Pubitemid 19274956)
66. Lee, G.; Neve, R.L.; Kosik, K.S. The microtubule binding domain of tau protein. Neuron 1989, 2, 1615-1624.
67. Ledesma, M.D.; Medina, M.; Avila, J. The in vitro formation of recombinant tau polymers: Effect of phosphorylation and glycation. Mol. Chem. Neuropathol. 1996, 27, 249-258. (Pubitemid 26142649)
68. Iqbal, K.; Liu, F.; Gong, C.X.; Alonso Adel, C.; Grundke-Iqbal, I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 2009, 118, 53-69.
69. Alonso, A.C.; Grundke-Iqbal, I.; Iqbal, K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 1996, 2, 783-787. (Pubitemid 26225094)
70. Alonso, A.D.; Grundke-Iqbal, I.; Barra, H.S.; Iqbal, K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. USA 1997, 94, 298-303.
71. Hernandez, F.; Avila, J. Tauopathies. Cell Mol. Life Sci. 2007, 64, 2219-2233. (Pubitemid 47347961)
72. Avila, J.; Leon-Espinosa, G.; Garcia, E.; Garcia-Escudero, V.; Hernandez, F.; Defelipe, J. Tau phosphorylation by GSK3 in different conditions. Int. J. Alzheimer's Dis. 2012, 2012, 578373.
73. Castellani, R.J.; Nunomura, A.; Lee, H.G.; Perry, G.; Smith, M.A. Phosphorylated tau: Toxic, protective, or none of the above. J. Alzheimer's Dis. 2008, 14, 377-383.
74. Iqbal, K.; Flory, M.; Khatoon, S.; Soininen, H.; Pirttila, T.; Lehtovirta, M.; Alafuzoff, I.; Blennow, K.; Andreasen, N.; Vanmechelen, E.; et al. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann. Neurol. 2005, 58, 748-757.
75. Avila, J. Intracellular and extracellular tau. Front. Neurosci. 2010, 4, 49.
76. Hanger, D.P.; Anderton, B.H.; Noble, W. Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 2009, 15, 112-119.
77. Morishima-Kawashima, M.; Hasegawa, M.; Takio, K.; Suzuki, M.; Yoshida, H.; Watanabe, A.; Titani, K.; Ihara, Y. Hyperphosphorylation of tau in PHF. Neurobiol. Aging 1995, 16, 365-371.
78. Hanger, D.P.; Byers, H.L.; Wray, S.; Leung, K.Y.; Saxton, M.J.; Seereeram, A.; Reynolds, C.H.; Ward, M.A.; Anderton, B.H. Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J. Biol. Chem. 2007, 282, 23645-23654. (Pubitemid 47311907)
79. Medina, M. Recent developments in tau-based therapeutics for neurodegenerative diseases. Recent Pat. CNS Drug Discov. 2011, 6, 20-30.
80. Lovestone, S.; Reynolds, C.H. The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997, 78, 309-324. (Pubitemid 27170324)
81. Martin, L.; Latypova, X.; Wilson, C.M.; Magnaudeix, A.; Perrin, M.L.; Terro, F. Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A. Ageing Res. Rev. 2013, 12, 39-49.
82. Caillet-Boudin, M.L.; Delacourte, A. Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells. Neuroreport 1996, 8, 307-310. (Pubitemid 126785579)
83. Shea, T.B.; Fischer, I. Phosphatase inhibition in human neuroblastoma cells alters tau antigenicity and renders it incompetent to associate with exogenous microtubules. FEBS Lett. 1996, 380, 63-67. (Pubitemid 26058733)
84. Liu, F.; Grundke-Iqbal, I.; Iqbal, K.; Gong, C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 2005, 22, 1942-1950.
85. Liu, R.; Pei, J.J.; Wang, X.C.; Zhou, X.W.; Tian, Q.; Winblad, B.; Wang, J.Z. Acute anoxia induces tau dephosphorylation in rat brain slices and its possible underlying mechanisms. J. Neurochem. 2005, 94, 1225-1234.
86. Grueninger, F.; Bohrmann, B.; Christensen, K.; Graf, M.; Roth, D.; Czech, C. Novel screening cascade identifies MKK4 as key kinase regulating Tau phosphorylation at Ser422. Mol. Cell Biochem. 2011, 357, 199-207.
87. Seidel, D.; Krinke, D.; Jahnke, H.G.; Hirche, A.; Kloss, D.; Mack, T.G.; Striggow, F.; Robitzki, A. Induced tauopathy in a novel 3D-culture model mediates neurodegenerative processes: A real-time study on biochips. PLoS One 2012, 7, e49150.
88. Kunze, A.; Meissner, R.; Brando, S.; Renaud, P. Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies. Biotechnol. Bioeng. 2011, 108, 2241-2245.